Skip to content
★ Sign in to follow
DH

Derek Hedges

Executive
Athenahealth Inc
Total declarations
30
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (12 ops.)
€1.8M

Latest filing published 03 May 2012 for ATHENAHEALTH INC, €119k.

Insider track record

Disclosed buys
0
Disclosed sells
12
Signal history

No signal scores available.

Derek Hedges: trading record in brief

All filings by Derek Hedges on record concern Athenahealth Inc. We count 30 filings; the first trade dates from 1 April 2010 and the latest from 2 May 2012.

On the market, this insider has only sold: 12 sales, €1.8M in total. Outside the open market, there are 8 share grants and 10 option exercises. So far in 2012, the count stands at no purchases and 5 sales.

On 3 May 2012 came the latest disclosure, an open-market sale for €119k in Athenahealth Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Derek Hedges

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations29 total
  • ▼
    VP Business DevelopmentExecutivesAthenahealth Inc
    156,096 USD0SEC
    2,143 shares@ US$72.84Common StockSEC:0001209191-12-025630:0
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    159,993 USD0SEC
    4,350 shares@ US$36.78Common StockSEC:0001209191-12-012463:0
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    81,800 USD0SEC
    2,500 shares@ US$32.72Common StockSEC:0001209191-12-012463:1
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    128,350 USD0SEC
    5,000 shares@ US$25.67Common StockSEC:0001209191-12-012463:2
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    789,684 USD0SEC
    11,850 shares@ US$66.64Common StockSEC:0001209191-12-012463:3
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    45,561 USD0SEC
    684 shares@ US$66.61Common StockSEC:0001209191-12-012463:4
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    46,613 USD0SEC
    700 shares@ US$66.59Common StockSEC:0001209191-12-012463:5
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    86,864 USD0SEC
    1,293 shares@ US$67.18Common StockSEC:0001209191-12-012463:6
  • ◆
    SVP Business DevelopmentExecutivesAthenahealth Inc
    6,161 USD0SEC
    96 shares@ US$64.18Common StockSEC:0001209191-12-011179:0
  • ◆
    SVP Business DevelopmentExecutivesAthenahealth Inc
    35,299 USD0SEC
    550 shares@ US$64.18Common StockSEC:0001209191-12-011179:1
  • ◆
    SVP Business DevelopmentExecutivesAthenahealth Inc
    0SEC
    12,500 shares0Common StockSEC:0001209191-11-020680:0
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    27,713 USD0SEC
    3,750 shares@ US$7.39Common StockSEC:0001209191-11-012396:0
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    81,800 USD0SEC
    2,500 shares@ US$32.72Common StockSEC:0001209191-11-012396:1
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    128,350 USD0SEC
    5,000 shares@ US$25.67Common StockSEC:0001209191-11-012396:2
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    557,738 USD0SEC
    12,199 shares@ US$45.72Common StockSEC:0001209191-11-012396:3
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    4,606 USD0SEC
    100 shares@ US$46.06Common StockSEC:0001209191-11-012396:4
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    4,612 USD0SEC
    100 shares@ US$46.12Common StockSEC:0001209191-11-012396:5
  • ◆
    SVP Business DevelopmentExecutivesAthenahealth Inc
    4,257 USD0SEC
    89 shares@ US$47.83Common StockSEC:0001209191-11-010619:0
  • ◆
    SVP Business DevelopmentExecutivesAthenahealth Inc
    26,593 USD0SEC
    556 shares@ US$47.83Common StockSEC:0001209191-11-010619:1
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    66,203 USD0SEC
    1,385 shares@ US$47.80Common StockSEC:0001209191-11-010619:2
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    163,600 USD0SEC
    5,000 shares@ US$32.72Common StockSEC:0001209191-11-008081:0
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    250,700 USD0SEC
    5,000 shares@ US$50.14Common StockSEC:0001209191-11-008081:1
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    128,350 USD0SEC
    5,000 shares@ US$25.67Common StockSEC:0001209191-10-051828:0
  • ▼
    SVP Business DevelopmentExecutivesAthenahealth Inc
    200,000 USD0SEC
    5,000 shares@ US$40.00Common StockSEC:0001209191-10-051828:1
  • ◇
    SVP Business DevelopmentExecutivesAthenahealth Inc
    2,860 USD0SEC
    500 shares@ US$5.72Common StockSEC:0001209191-10-051493:0

25 of 29 declarations